Latest International Growth News

Page 4 of 20
Tinybeans Group reported a robust Q4 FY26 with total revenue surging 57% to US$1.81 million and adjusted EBITDA more than doubling to US$232,000. The company achieved its third consecutive quarter of operating cash inflows and ended the period with US$1.76 million in cash and zero debt.
Sophie Babbage
Sophie Babbage
28 July 2026
AML3D Limited closed FY26 with a record $29 million order book, driven by US defence contracts and a $12 million investment to double its Ohio manufacturing capacity. The company’s cash receipts rose 20% to $10.4 million, while its sales pipeline expanded to $78 million.
Victor Sage
Victor Sage
27 July 2026
BLS Pharmaceuticals capped FY26 with record revenue and EBITDA, boosted by international expansion and major contracts, setting the stage for further growth in FY27.
Victor Sage
Victor Sage
27 July 2026
I Synergy Group has appointed Anson Heng as Executive Chairman and Managing Director to spearhead its strategic cooperation with Macau Direch, formalised through a non-binding MoU targeting blockchain, AI, and digital asset initiatives.
Sophie Babbage
Sophie Babbage
23 July 2026
Atomo Diagnostics reported a 40% increase in FY26 revenue to $5.3 million, driven by a surge in HIV self-test sales and new OEM customer orders. The company is advancing its syphilis and liver test developments while enhancing manufacturing capacity.
Ada Torres
Ada Torres
23 July 2026
Activeport signs GOIP Globalnet to its Global Edge network, marking the third international carrier deal in a week and reinforcing its strategy for recurring revenue growth.
Sophie Babbage
Sophie Babbage
20 July 2026
SPC Global reported solid Q4 FY26 growth driven by domestic beverage sales and a 50.8% jump in international revenue, while a $100 million equity raise slashed net leverage and paved the way for improved cash flow in FY27.
Victor Sage
Victor Sage
8 July 2026
Biome Australia has posted a 30% increase in FY26 sales revenue to $23.9 million, driven by strong domestic demand and strategic moves into onshore manufacturing and international markets.
Ada Torres
Ada Torres
1 July 2026
RTO Limited reported a net loss of NZD 173,831 for the year ended 31 March 2026, remaining inactive while actively seeking a reverse takeover target. The company faces going concern uncertainty but secured shareholder support with a $200k loan agreement post-year-end.
Claire Turing
Claire Turing
24 June 2026
The Calmer Co. has won Coles' approval for its innovative Fiji Kava® FZZR™ product, extending its Australian supermarket reach while gearing up for a broader U.S. retail rollout supported by a key brokerage partnership.
Victor Sage
Victor Sage
24 June 2026
AFT Pharmaceuticals surged 22% to NZ$254.7 million revenue in FY26, surpassing profit guidance and securing FDA approval to advance a pivotal injectable iron Phase III trial targeting a $7.4 billion market. The company is poised for further global expansion and product launches in FY27.
Ada Torres
Ada Torres
24 June 2026
AFT Pharmaceuticals delivered a 22% revenue jump in FY26 to NZD 254.7 million, surpassing profit guidance and expanding its footprint to 87 countries. The company is advancing multiple R&D projects, including a pivotal Phase III injectable iron trial, while targeting over NZD 300 million in revenue for FY27.
Ada Torres
Ada Torres
24 June 2026

Browse the archive

Full archive